scholarly journals Inhibitory effect of traditional herbal (kampo) medicines on the replication of human parainfluenza virus type 2 in vitro

2021 ◽  
Vol 15 (4) ◽  
pp. 180-188
Author(s):  
Jun Uematsu ◽  
Hidetaka Yamamoto ◽  
Sahoko Kihira ◽  
Kae Sakai-Sugino ◽  
Yuhko Ishiyama ◽  
...  
2010 ◽  
Vol 56 (5) ◽  
pp. 613-617 ◽  
Author(s):  
Hidetaka Yamamoto ◽  
Yukari Ura ◽  
Miho Tanemura ◽  
Aoi Koyama ◽  
Sayaka Takano ◽  
...  

2005 ◽  
Vol 86 (1) ◽  
pp. 151-158 ◽  
Author(s):  
B. Precious ◽  
D. F. Young ◽  
L. Andrejeva ◽  
S. Goodbourn ◽  
R. E. Randall

Previous work has documented that the V protein of simian virus 5 (SV5) targets STAT1 for proteasome-mediated degradation, whilst the V protein of human parainfluenza virus type 2 (hPIV2) targets STAT2. Here, it was shown that the processes of ubiquitination and degradation could be reconstructed in vitro by using programmed rabbit reticulocyte lysates. Using this system, the addition of bacterially expressed and purified SV5 V protein to programmed lysates was demonstrated to result in the polyubiquitination and degradation of in vitro-translated STAT1, but only if human STAT2 was also present. Surprisingly, in the same assay, purified hPIV2 V protein induced the polyubiquitination of both STAT1 and STAT2. In the light of these in vitro results, the specificity of degradation of STAT1 and STAT2 by SV5 and hPIV2 in tissue-culture cells was re-examined. As previously reported, STAT1 could not be detected in human cells that expressed SV5 V protein constitutively, whilst STAT2 could not be detected in human cells that expressed hPIV2 V protein, although the levels of STAT1 may also have been reduced in some human cells infected with hPIV2. In contrast, STAT1 could not be detected, whereas STAT2 remained present, in a variety of animal cells, including canine (MDCK) cells, that expressed the V protein of either SV5 or hPIV2. Thus, the V protein of SV5 appears to be highly specific for STAT1 degradation, but the V protein of hPIV2 is more promiscuous.


Virology ◽  
2007 ◽  
Vol 362 (1) ◽  
pp. 85-98 ◽  
Author(s):  
Machiko Nishio ◽  
Masato Tsurudome ◽  
Hisamitsu Ishihara ◽  
Morihiro Ito ◽  
Yasuhiko Ito

2010 ◽  
Vol 85 (2) ◽  
pp. 725-732 ◽  
Author(s):  
M. Nishio ◽  
M. Tsurudome ◽  
D. Garcin ◽  
H. Komada ◽  
M. Ito ◽  
...  

2021 ◽  
Author(s):  
Naoki Saka ◽  
Yusuke Matsumoto ◽  
Keisuke Ohta ◽  
Daniel Kolakofsky ◽  
Machiko Nishio

Paramyxovirus genomes, like that of human parainfluenza virus type 2 (hPIV2), are precisely a multiple of six nucleotides long (“rule of six”), in which each nucleoprotein subunit (NP) binds precisely 6 nucleotides. Ten residues of its RNA binding groove contact the genome RNA; but only one, Q202, directly contacts a nucleotide base. Mutation of NP Q202 leads to two phenotypes; the ability of the viral polymerase to replicate minigenomes with defective bipartite promoters where NP wt is inactive, and the inability to rescue rPIV2 carrying this point mutation by standard means. The absence a rPIV2 NP Q202A prevented further study of this latter phenotype. By extensive and repeated co-cultivation of transfected cells, a rPIV2 carrying this mutation was finally recovered, and this virus was apparently viable due to the presence of an additional NP mutation (I35L). Our results suggest that these two phenotypes are due to separate effects of the Q202 mutation, and that of the problematic rescue phenotype may be due to the inability of the transfected cell to incorporate viral nucleocapsids during virus budding. Importance Paramyxovirus genomes are contained within a non-covalent homopolymer of its nucleoprotein (NP) and form helical nucleocapsids (NC) whose 3’ ends contain the promoters for the initiation of viral RNA synthesis. This work suggests that these NC 3’ ends may play another role in the virus life cycle, namely via their specific interaction with virus modified cell membranes needed for the incorporation of viral NCs into budding virions.


Virology ◽  
2019 ◽  
Vol 531 ◽  
pp. 93-99 ◽  
Author(s):  
Natsuko Yumine ◽  
Yusuke Matsumoto ◽  
Keisuke Ohta ◽  
Masayoshi Fukasawa ◽  
Machiko Nishio

Virology ◽  
2019 ◽  
Vol 533 ◽  
pp. 108-114 ◽  
Author(s):  
Keisuke Ohta ◽  
Yusuke Matsumoto ◽  
Machiko Nishio

Sign in / Sign up

Export Citation Format

Share Document